A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)
NCT03597295
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Squamous Cell Carcinoma of Anal Canal
Interventions
DRUG:
Retifanlimab
Sponsor
Incyte Corporation